| Literature DB >> 31040225 |
Yoshiki Narimatsu1, Hiren J Joshi2, Katrine T Schjoldager2, John Hintze2, Adnan Halim2, Catharina Steentoft2, Rebecca Nason2, Ulla Mandel2, Eric P Bennett2, Henrik Clausen2, Sergey Y Vakhrushev3.
Abstract
Most proteins trafficking the secretory pathway of metazoan cells will acquire GalNAc-type O-glycosylation. GalNAc-type O-glycosylation is differentially regulated in cells by the expression of a repertoire of up to twenty genes encoding polypeptide GalNAc-transferase isoforms (GalNAc-Ts) that initiate O-glycosylation. These GalNAc-Ts orchestrate the positions and patterns of O-glycans on proteins in coordinated, but poorly understood ways - guided partly by the kinetic properties and substrate specificities of their catalytic domains, as well as by modulatory effects of their unique GalNAc-binding lectin domains. Here, we provide the hereto most comprehensive characterization of nonredundant contributions of individual GalNAc-T isoforms to the O-glycoproteome of the human HEK293 cell using quantitative differential O-glycoproteomics on a panel of isogenic HEK293 cells with knockout of GalNAc-T genes (GALNT1, T2, T3, T7, T10, or T11). We confirm that a major part of the O-glycoproteome is covered by redundancy, whereas distinct O-glycosite subsets are covered by nonredundant GalNAc-T isoform-specific functions. We demonstrate that the GalNAc-T7 and T10 isoforms function in follow-up of high-density O-glycosylated regions, and that GalNAc-T11 has highly restricted functions and essentially only serves the low-density lipoprotein-related receptors in linker regions (C6XXXTC1) between the ligand-binding repeats.Entities:
Keywords: ETD; GALNT; Glycoproteomics; Glycosylation; Mass Spectrometry; Post-translational modifications*; Tandem Mass Spectrometry
Mesh:
Substances:
Year: 2019 PMID: 31040225 PMCID: PMC6601209 DOI: 10.1074/mcp.RA118.001121
Source DB: PubMed Journal: Mol Cell Proteomics ISSN: 1535-9476 Impact factor: 5.911